Introduction of International Fellowship 'Koh Chang-Soon Fellowship'
페이지 정보
작성자 : NMSNUH 작성일2019-12-17 조회1,268회첨부파일
-
79회 다운로드 DATE : 2019-12-17 12:19:45
관련링크
본문
Koh Chang-Soon Fellowship 2019
1. Introduction
ABOUT US
The Department of Nuclear Medicine at Seoul National University Hospital is committed to improving health through excellence in patient care, research, and education. Based on the knowledge about functions of the organs and nature of diseases, we provide superb medical services for diagnosing and treating a variety of diseases. To develop more effective strategies to conquer diseases, we are actively pursuing biomedical researches through the close collaboration between physicians and scientists. In addition, we manage training programs for the future physicians and scientists, not only for intramural members but also for international applicants. Twelve faculty members, 50 nuclear medicine technologists, 40 researchers, 15 nursing or administrative members are working for the patient care and researches.
From 2002 to 2006, the former Professor Myung Chul Lee had been the president of World Federation of Nuclear Medicine and Biology (WFNMB) and Prof. June-Key Chung had been the secretary general of WFNMB. With our experience of rapid development, we are trying to dedicate ourselves to the worldwide expansion of nuclear medicine, especially in the developing countries. For that purpose, we are actively participating in the program of WFNMB, ARCCNM (Asian Regional Cooperative Council for Nuclear Medicine), ASNM (AsianSchool of Nuclear Medicine), ASMI (Asian Societies of Molecular Imaging), and so on. At present, we are the only cooperative site of IAEA (International Atomic Energy Agency) for the education and training of nuclear medicine, and we are managing fellowship and international scholarship programs.
PATEINT CARE
As a world-leading group in the field of nuclear medicine, we provide state-of-the-art medical services in diagnosing and treating disease;
n Diagnostic Imaging
Using diverse radioactive tracers, nuclear medicine can visualize the status of diseases and monitor effect of a treatment through medical imaging in living body. For diagnostic imaging, we currently have 8 gamma cameras, 2 SPECT/CT scanners, 3 PET/CT scanners, and 1 PET/MR scanner.
1. PET
PET (positron emission tomography) is an imaging tool using positron-emitting radiotracers. Various PET tracers have been developed and are in use. With an adequate radiotracer, cancer lesions, viable myocardium, and metabolic status of brain can be diagnosed. At present, we can offer various PET tracers with active support of radiopharmacy.
• 18F-FDG: For glucose metabolism
• 18F-FLT: For nucleic acid metabolism
• 18F-FP-CIT: For DA transporter
• 11C-Methionine: For amino acid metabolism
• 11C-Acetate: For fatty acid metabolism
• 11C-PIB: For amyloid plaques in Alzheimer’s disease
• 68Ga-RGD: For angiogenesis
• 13N-Ammonia: For myocardial perfusion
• Etc.
2. Gamma camera, SPECT, and SPECT/CT
Gamma camera is a traditional imaging tool in nuclear medicine, using diverse radiotracers labeled with gamma-emitters such as 99mTc, 201Tl, 123I. SPECT (single photon emission computed tomography) is a reconstructed gamma camera image to show 2-D tomographic images. Many gamma camera imaging is available in our department.
• Bone scan
• Myocardial perfusion SPECT (/CT)
• Brain perfusion SPECT (/CT)
• Thyroid scan
• Renal scan
• Liver scan
• Hepatobiliary scan
• White blood cell scan (for infection)
• Parathyroid scan (SPECT/CT)
• Salivary gland scan
• Lymphangiography
• Spleen scan
• Etc.
n Diagnostic Laboratory
In aid of diagnosis, our department operates diagnostic laboratory using radiotracers, in which approximately 700,000 cases of laboratory studies are performed in a year. Assays using radiotracers can provide extremely sensitive and accurate results. RIA (radioimmunoassay) and IRMA (immunoradiometric assay) studies are performed to measure very small amounts of biological materials such as hormones and tumor markers. In addition, some important functional parameters of living body such as GFR (glomerular filtration rate) can be measured in the laboratory.
• Thyroid hormone (T3, T4, TSH, Tg, TgAb, etc.)
• Sex hormone (LH, FSH, etc.)
• Viral markers (HBV, HCV, etc.)
• Tumor markers (AFP, CEA, PSA, etc.)
n Radioisotope Therapy Clinic
Radioisotope therapy is a kind of cancer therapy using radiopharmaceuticals that emit destructing radiation. Targeted radiopharmaceuticals can be accumulated in cancer tissue and destruct them by radiation. Radioisotope therapy clinic of our department has been operated for more than 40 years. The most important target of radioisotope therapy is thyroid cancer, at present. However, we are trying to expand the scope of radioisotope therapy by developing novel therapeutic radiopharmaceuticals.
At present, clinics for outward patients and 1 therapy room is in operation for several diseases.
• Thyroid Cancer
• Palliation of metastatic bone pain
• Lymphoma
• Neuroendocrine tumors
• Etc.
RESEARCHES
We are pursuing many research programs not only for the purpose of academic development but also for the purpose of enhancing the quality of medical services. As one of the world’s best research centers, our department has made every endeavor to develop innovative methods in diagnosis and therapeutics of diseases. As a result, we present 20~30 research articles in the Annual Meeting of the Society of Nuclear Medicine in USA every year, by which we are within the top three groups in the world. We have diverse research laboratories in harmony.
n Clinical Nuclear Medicine
• General nuclear medicine
• PET oncology with new tracers
• Nuclear cardiac imaging for ischemic heart disease and atherosclerosis
• Neuroimaging for Alzheimer disease, vascular diseases, and movement disorder
• Radioisotope therapy
• Innovative medical fusion imaging (PET/MRI)
• Translational research of molecular imaging
n Radiochemistry
• Development of new PET tracers for tumor using angiogenesis and hypoxia
• Development of new PET tracers for ischemic heart disease
• Development of 99mTc-based radiopharmaceuticals
• Development of therapeutic radiopharmaceuticals
• Improvement in compounding methods (developing kits)
n Nuclear Medicine Physics
• Development of new imaging devices (PET/MRI, animal SPECT)
• Enhancement of image reconstruction (new algorithms)
• Tracer kinetics analysis for new imaging agents
• Radiation dosimetry
n Molecular Imaging and Nanomedicine
• Reporter gene imaging for gene or protein expression
• Gene therapy using radioisotope
• Development of biomarkers for targeted imaging and therapy (miRNA, aptamer)
• Application of nanoparticle carriers in vivo
• Cell trafficking imaging
INTRODUCTION TO KOH CHANG-SOON FELLOWSHIP PROGRAM
Koh Chang-Soon Memorial Projects remember the spirit and pays a tribute to the late professor for his contribution to the development and emergence of nuclear medicine in Korea. The late Professor Koh established nuclear medicine and taught his trainees the spirit of “challenge and harmony”. His teachings encouraged his students for a long time, and they are entirely indebted to Professor Koh for the present success and the future of nuclear medicine in Korea.
International fellows had been trained for a period of 1 week to 6 months in ‘IAEA Collaborating Center for Nuclear Medicine’ in Seoul National University, which was established and named by IAEA in 2004. A new opportunity of international fellowship started in 2010, which supported the following three visiting scholars. The International Visiting Fellows, irrespective of physician or scientist/engineer, has been named as ‘Koh Chang-Soon Fellow’.
2. Faculty Members for Education & Training
Part
|
Name
|
Title
|
Specialty
|
MD |
Edmund Euishin Kim Dong Soo Lee Wook Kang Keon Gi Jeong Cheon Jin Chul Paeng Hong Yoon Choi |
Visiting Professor Professor, Former Chairman Professor, Chairman Professor Professor Professor |
Oncology, Therapy, MI Neurology, Cardiology, MI Oncology, MI, Nanomedicine Oncology, Therapy, MI Cardiology, Therapy, MI Neurology, Data Science, MI |
PhD |
Jae Min Jeong Jae Sung Lee Hyewon Youn Yun Sang Lee Do Won Hwang Hye Jin Kang Mi Jeong Kim Hye Kyung Lee Myung Geun Song Yoori Choi Younghwa Kim |
Professor Professor Professor Associate Professor (Research) Associate Professor (Research) Associate Professor (Research) Associate Professor (Research) Associate Professor (Research) Associate Professor (Research) Associate Professor (Research) Associate Professor (Research) |
Radiopharmacy NM Physics MI, Molecular biology Radiopharmacy Molecular Imaging Cognitive Science Molecular Imaging Cognitive Science MI, Molecular Biology Molecular Imaging Molecular Biology |
3. Education & Training Program
(1 Year Course)
Month
|
Purpose
|
Training Items
|
Remarks
|
1 |
- Adaptation - Introduction |
1. Introduction of each Labs in SNUH NM 2. Basic Image Readings (full-time) (including general scan and PET) 3. Structured Lectures by Faculty 4. Experience on Technical Affairs (PET center) |
Participation in ① Routine Conferences ② Classes of Gr. School (option) |
2 |
- Expertise |
1. Image Reading (part-time) (with charge, mentor-supporting) 2. Advanced Training on Specific Subject (chosen by the trainee) |
Participation in ① Routine Conferences ② Classes of Gr. School (option) |
3-5 |
- Expertise - Research |
1. Image Reading (part-time) (with charge, mentor-supporting) 2. Research Affairs (chosen by the trainee) - Clinical Research - Basic / Translational Research |
Participation in ① Routine Conferences ② Classes of Gr. School (option) ③ Specific Lab Meeting |
6 |
- Expansion of Experience |
1. Research Affairs (chosen by the trainee) - Writing of original research paper 2. Tour to Major NM Centers in Korea - SNUBH - NCC - Others (AMC, SMC, etc) |
Participation in ① Routine Conferences ② Classes of Gr. School (option) ③ Specific Lab Meeting |
7~12 |
- Research |
1. Research Affairs (chosen by the trainee) - Writing of original research paper
|
Participation in ① Routine Conferences ② Classes of Gr. School (option) ③ Specific Lab Meeting |
4. Routine Schedule in Clinical Practice
Time
|
Mon
|
Tue
|
Wed
|
Thu
|
Fri
|
08:00 ~ 09:00 (Conference) |
|
Lit. Review / Case Review |
Mini Symposium |
Staff Lecture |
Research Meeting |
09:00 ~ 10:00 |
Pre-reading |
Pre-reading |
Pre-reading |
Pre-reading |
Pre-reading |
10:00 ~ 12:00 |
Reading with Faculty |
Reading with Faculty/ RI Therapy Clinic |
Reading with Faculty / RI Therapy Clinic |
Reading with Faculty |
Reading with Faculty |
12:00 ~ 13:00 |
Lunch |
Lunch |
Lunch |
Lunch |
Lunch |
13:00 ~ 15:00 |
Pre-reading / RI Therapy Clinic |
Pre-reading |
Pre-reading |
Pre-reading / RI Therapy Clinic |
Pre-reading |
15:00 ~ 17:00 |
Reading with Faculty |
Reading with Faculty |
Reading with Faculty |
Reading with Faculty |
Reading with Faculty |
17:00 ~ |
|
|
|
|
|
5. Assistance for Application to Training/Fellowship Program
(1) Homepages
Seoul National University Hospital http://www.snuh.org/english/,
SNUH Cancer Hospital http://cancer.snuh.org/
Department of Nuclear Medicine, SNUH http://nm.snu.ac.kr/emain.php
Information of Korea http://www.visitkorea.com/
Information of Seoul http://www.visitseoul.net/
Korean Society of Nuclear Medicine http://www.ksnm.or.kr/eng
ARCCNM http://www.arccnm.org/
1) Applicants must have an MD
degree in Asia and nuclear medicine practice licensure according to each
country’s rules and regulations.
2) He or
she should have nuclear medicine board (if applicable) or its equivalent experience
in this field.
3) Excellent
competence in oral and written English is essential.
4) Young
nuclear medicine physician who is or will be in charge of public sector of
academic medical community shall be favored.
Applicants should send
1. Application Form
1-1. Application
1-2. Recommendation (At least 2 referees who are nuclear medicine leaders in their home country. We will directly contact them for the applicant's evaluation.)
1-3. Study Plan (describing your wish or vision during training period with a paragraph of further plans after coming back home)
1-4. Commitment
2. Copy of MD License
3. Copy of Diploma or Certificate of Graduation
4. Employment Certificate
5. Copy of Passport
6. Health Certificate-Immunization and Tuberculosis (TB) Screening Record
7. Health Certificate- TB Screening Questionnaire
5. Assistance for Application to Training/Fellowship Program
(1) Homepages
Seoul National University Hospital http://www.snuh.org/english/,
SNUH Cancer Hospital http://cancer.snuh.org/
Department of Nuclear Medicine, SNUH http://nm.snu.ac.kr/emain.php
Information of Korea http://www.visitkorea.com/
Information of Seoul http://www.visitseoul.net/
Korean Society of Nuclear Medicine http://www.ksnm.or.kr/eng
ARCCNM http://www.arccnm.org/
(2) Contact person
Dong Soo Lee, M.D.Ph.D.
Professor, Professor of Department of Nuclear Medicine
Seoul National University College of Medicine
Seoul 110-744 Korea
Fax 82-2-745-7690
Tel 82-2-2072-2501
Via
E-mail: choi06@snu.ac.kr, sangeun0810@snu.ac.kr
For further inquiry please contact International Program Manager, Sangeun Lee (sangeun0810@snu.ac.kr).
Application & Health Certificate
Form 1. Application
Form 2. Recommendation
Form 3. Study plan
Form 4. Commitment
Health Certificate-Immunization and Tuberculosis (TB) Screening Record
Health Certificate- TB Screening Questionnaire
Also, each candidate's OFFICIAL certificate and documents as a medical doctor are needed
1. Medical License
2. Certificate of Degrees
3. Certificate of Employment
4. Your Passport